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ABSTRACT | Was evaluated the maximum load supported 
by the grastrocnemius muscle of female rats after the min-
istering of Cystoseira canariensis, either associated or not 
to swimming. Twenty-eight young Wistar female rats were 
used, divided into 4 groups: control (C, n=7); supplement (S, 
n=7); supplement and swimming (SSw, n=7);  swimming (Sw, 
n=7). Each one pertaining to the groups S and SSw received 
20 mg of myostatin inhibitor per day. The swimming con-
sisted in an aerobe protocol, three times in a week, during 
eight weeks. The right grastrocnemius muscle of each ani-
mal was removed and a tension test was performed in an 
Emic testing machine. The results (Mean±SEM) were evalu-
ated through ANOVA and Tukey test (p<0.05). A significant 
difference for maximum load (in N) was verified among the 
groups C (35.41±1.06) and S (39.98±1.15); Sw (27.94±2.19) and 
S (39.98±1.15); Sw (27.94±2.19) and SSw (37.78±1.28). In rela-
tion to the stretching at the maximum limit (in x10-3 m) at the 
maximum load, the group SSw obtained a value (20.68±1.19) 
significantly greater than the groups C (17.15±1.11), S and 
Sw (16.11±1.60). There was a significant difference for body 
weight gain among the groups treated with supplement 
and supplement associated to the swimming, with smaller 
values for this last. The myostatin inhibitor either, associated 
or not to the swimming, promotes an increase of resistance 
to the maximum load in the tension test in grastrocnemius 
muscle of young female rats.
Supplement with Cystoseira canariensis promotes 
an increase of resistance to the maximum load in 
the grastrocnemius muscle of female rats
Suplemento com Cystoseira canariensis promove aumento de resistência à carga 
máxima em músculo gastrocnêmio de ratas
Suplemento con Cystoseira canariensis promueve aumento de la resistencia a la carga 
máxima en músculo gastrocnemio de ratas
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RESUMO | O objetivo deste trabalho foi avaliar a carga 
máxima suportada pelo músculo gastrocnêmio de ratas 
após intervenção com Cystoseira canariensis, associado 
ou não à natação. Foram utilizadas 28 ratas Wistar, divi-
didas em 4 grupos: controle (C, n=7); suplemento (S, n=7); 
suplemento e natação (SN, n=7); e natação (N, n=7). Cada 
animal pertencente aos grupos S e SN recebeu 20 mg de 
inibidor de miostatina por dia. A natação consistiu em um 
protocolo aeróbio, três vezes por semana, durante oito se-
manas. Após o período de treinamento, foi retirado o mús-
culo gastrocnêmio direito de cada animal e realizado teste 
de tração em uma máquina de ensaio Emic. Os resultados 
(Média±DP) foram avaliados por meio de ANOVA e teste 
de Tukey (p<0,05). Houve diferença significativa para car-
ga no limite máximo (em N) entre os grupos C (35,41±1,06) 
e S (39,98±1,15); N (27,94±2,19) e S (39,98±1,15); N (27,94±2,19) 
e SN (37,78±1,28). Em relação ao alongamento no limite 
máximo (em x10-3 m), o grupo SN obteve valor (20,68±1,19) 
significativamente maior do que os grupos C (17,15±1,11) e 
N (16,11±1,60). Houve diferença significativa para ganho de 
massa corporal entre os grupos tratados com suplemento 
e suplemento associado à natação, com menores valores 
para este último. O inibidor de miostatina, associado ou 
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INTRODUCTION
The hypertrophy of the skeletal muscle is a result of in-
dividual growth in the cross-sectional region of muscle 
fibers that results in the enlargement of its cross-sectio-
nal section, which, on the other hand, is a reflex of the 
growing number and size of myofibrils and the adap-
tation of sarcomeres inside the muscle fiber1. Among 
the mechanisms that are in charge of controlling the 
increasing size of the muscle fiber, it is important to 
consider myostatin, since it is a potent regulator of gro-
wth and myoblast differentiation2.
Myostatin is initially expressed during the formation 
of the musculoskeletal cell, being known as a growing 
differentiator-8 (GDF-8), from the superfamily of the 
tumor growing factor beta (TGF- β). It inhibits the in-
creasing muscle trophism by inactivating the myoblasts 
and satellite cells3-6.
In the skeletal muscle, myostatin is transcribed as a 
messenger RNA (mRNA), which codified a precursor 
protein containing 335 amino acids. In adult rats, myo-
statin circulates in its a latent form in the blood flow, and 
it can be activated in an acid environment, similarly to 
TGF- β. The excessive expression of systemic myostatin 
among adult female rats induces deep muscle mass and 
fat loss, without, however, decreasing the absorption of 
nutrients7. Also, the decreasing mRNA expression has 
been identified for myostatin in the skeletal muscle of 
rats exposed to physical training8.
 There are only a few indicators of myostatin inhibi-
tors in literature, even though they have been consid-
ered as probable candidates to genic therapy9-11. Studies 
suggest that supplementation containing Cystoseira ca-
nariensis can promote the loss of body fat mass and gain 
of muscle mass, once this compound, which is a deriva-
tive of brown seaweed, would be connected to myostatin 
and, apparently, it could reduce the biological effects of 
this protein12-14. However, no studies approaching the 
effect of this supplementation on the resistance and 
muscle strength of rats have been found. Its importance 
for muscle mass control is in accordance with the need 
to develop studies focused on strength loss situations, 
be it due to lack of use or the absence of protein fila-
ments inside the myofibrils, or be it due to some specific 
diseases, syndromes or aging15,16.
The objective of this study was to verify the possible 
effect of the supplementation with Cystoseira canariensis, 
associated or not to swimming, on body mass and trac-
tion force of the gastrocnemius muscles in female rats. 
METHODOLOGY
Animals 
This study was characterized as being randomized and 
experimental. Twenty-eight female Wistar rats were 
used. They were 45 days old, with body mass of appro-
ximately 250 g, coming from and maintained in the 
Central Bioterium of UNIUBE. The animals were kept 
under a light regime (10 hours, bright, 14 hours, dark) 
and controlled temperature (25ºC). They were divided in 
four groups: control (C, n=7), without swimming or su-
pplementation; supplementation (S, n=7), with supple-
mentation; supplementation associated with swimming 
(SSw, n=7); they underwent the exercise protocol and 
received supplementation in the period; and swimming 
não à natação, promove aumento de resistência à carga máxima, 
no teste de tração, em músculo gastrocnêmio de ratas jovens.
Descritores | Miostatina; Natação; Força Muscular; Ratos Wistar.
RESUMEN  |  El objetivo de este trabajo fue evaluar la carga máxima 
soportada por el músculo gastrocnemio de ratas después de inter-
vención con Cystoseira canariensis, asociado o no con la natación. 
Se utilizaron 28 ratas Wistar, divididas en 4 grupos: control (C, n=7); 
suplemento (S, n=7); suplemento y natación (SN, n=7); y natación (N, 
n=7). Cada animal perteneciente a los grupos S y SN recibió 20 mg 
de inhibidor de miostatina por día. La natación consistió em un pro-
tocolo aeróbico, tres veces por semana, durante ocho semanas. Tras 
el período de entrenamiento, fue retirado el músculo gastrocnemio 
derecho de cada animal y realizado test de tracción en una máquina 
de ensayo Emic. Los resultados (Media±DP) fueron evaluados por 
ANOVA y test de Tukey (p<0,05). Hubo una diferencia significativa en 
la carga máxima ( en N) entre los grupos C (35,41±1,06) y S (39,98±1,15); 
N (27,94±2,19) y S (39,98±1,15); N (27,94±2,19) y SN (37,78±1,28). En 
cuanto al alargamiento en el límite máximo (en x10-3 m), el grupo SN 
obtuvo valor (20,68±1,19) significativamente mayor que los grupos C 
(17,15±1,11) y N (16,11±1.60). Hubo una diferencia significativa en el au-
mento de masa corporal entre los grupos tratados con suplemento 
y suplemento asociado con la natación, con valores más bajos para 
este último. El inhibidor de miostatina, asociado o no con la natación, 
promueve aumento de resistencia a la carga máxima, en el test de 
tracción, en músculo gastrocnemio de ratas jóvenes.




(Sw, n=7) — these were only submitted to the swim-
ming protocol. 
In order to conduct this study, according to the 
guidelines of the Research Ethics Committee, all 
of the principles proposed by some authors and rati-
fied by UNESCO were obeyed. In 1978, UNESCO 
elaborated the Declaration of Animal Rights. The ex-
periment was in accordance with all of the necessary 
precautions to avoid the suffering of each animal17,18. 
The project was approved by the Commission of Animal 
Experimentation of UNIUBE (Process n. 028/2009).
Treatment and exercise protocol
Animals in groups S and Ssw were treated with 
20 mg of the MyoblastTM supplement, which contains 
Cystoseira canariensis, diluted in water, in a daily dose for 
8 weeks, six days a week. 
Animals were trained with moderate chronic aer-
obe exercise (swimming), three times a week, on alter-
nate days, for eight weeks, based on a protocol adapted 
from several authors19,20. The temperature of the water 
was maintained between 30º and 35ºC, being changed 
daily. During the swimming period, time increased pro-
gressively. On the first day, it lasted 15 minutes; on the 
second day, 15 other minutes were added, and so on, 
successively, until the total time of 45 minutes. During 
the swimming activity, which was conducted in a tank 
measuring 1.5x0.90x0.70 m, the animal had overload 
(5% of body mass) attached to its tail. 
Studied variables
Body mass
Throughout the eight weeks of treatment, body mass 
values of the animals were verified weekly, in order to 
prepare the load that would be attached to the tail and to 
assess the probable weight gain. After the eight weeks, 
animals were euthanized with anesthetic overdose. 
Muscle tissue analysis
Traction trial
The traction trial consisted of the collection of the 
set right femur-gastrocnemius, calcaneus of female 
rats. The universal testing machine EMIC® − model 
DL3500, from the Laboratory of Odontology Material 
Research, at Universidade de Uberaba, equipped with a 
load cell of 50 kgf, was used to execute the mechani-
cal trial. The machine was directly connected to a 
microcomputer equipped with software that was able 
to obtain accurate load and stretching values. A spe-
cial device was used to fixate and conduct the muscle 
traction trials, so that the muscle origin and insertion 
could be preserved. 
The parameters adopted for the trial were: preload 
of 0.30 kgf, trial velocity of 10 mm/min; load limits and 
stretching of 8.00 kgf and 25 mm, respectively. After 
the conduction of each trial, the place of muscle fiber 
rupture was observed. For each load increase applied to 
the muscle, there was a resulting stretching value, which 
enabled the construction of graphics showing load ver-
sus stretching, by using the software Microsoft Excel 
Xp Professional®. 
Afterwards, the following mechanical properties 
were analyzed: load at maximum limit; stretching at 
maximum limit; and rigidity21-24.
Statistical analysis
The ANOVA test was used for the simultaneous analy-
sis of groups, and the Tukey-Kramer test was used to 
compare both groups; a significance level lower than 5% 
was adopted. 
RESULTS
A significant difference was observed for body mass 
gain between the groups treated with supplementation 
and supplementation associated with swimming, with 
lower values for the latter (Table 1).
In Table 1, values referring to load limit (LL) and 
maximum stretch limit (MSL) presented by the gas-
trocnemius muscle of the animals were observed. 
At the end of the experimental period, higher MSL val-
ues were observed for the SSw group, in comparison to 
the Sw group. Concerning LL, the SSw group present-
ed higher values than experimental groups C, S and Sw. 
Table 1. Body mass gain (g), maximum load (Sw), maximum stretch limit 
(x10-3 m) and rigidity (x103 N/m) in groups (C), (S), (Sw) and (SSw) (mean±SD)






C 67.5±15.01 35.41±1.06 17.15±1.11 3.07±0.31
S 92.3±18.04* 39.98±1.15* 18.71±2.31 3.22±0.28**
Sw 64.0±11.11*** 27.94±2.19 16.11±1.60 2.06±0.29
SSw 59.7±25.02 37.78±1.28**** 20.68±1.19***** 2.83±0.63
*p<0.05 versus C (Control); **p<0.05 versus Sw (Swimming); ***p<0.05 versus SSw 
(Supplementation and Swimming); ****p<0.05 versus Sw ; *****p<0.05 versus C and SSw 
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Rigidity value was significantly lower for the group that 
only swam, compared to the group that only received 
supplementation. For this property, no significant dif-
ferences were found between the other groups.
DISCUSSION
The objective of this study was to verify the possible 
variation in body mass and in the gain of resistance 
of the gastrocnemius muscle, among female rats in 
the traction test after a period of physical training 
with or without a supplementation containing a my-
ostatin inhibitor. Even though literature presents re-
levant work related to genic therapy and therapeutics 
to increase muscle mass11,25, no studies were observed 
that identified the variation of body mass in animals 
treated with myostatin inhibitor. It is worth to men-
tion that the aerobe exercise protocol was used, what 
would favor body mass loss. The myostatin inhibitor 
seems to have an anabolic effect on animals, which 
may have had strong action when not being associa-
ted with any therapy.
The myostatin inhibitor used in this work con-
tained Cystoseira canariensis, a polysaccharide deriving 
from brown seaweeds which with a complex group of 
macromolecules. This would facilitate its connection 
with myostatin and, consequently, the inactivation of 
this protein. There are also records that these polysac-
charides regulate some growing factors and cytokines, 
such as fibroblast growth factors, interferon, and some 
enzymes belonging to the family of TGF- -b12,26.
In a study conducted with humans by Willoughby13, 
who used supplements containing Cystoseira cana-
riensis combined with physical exercise, it was not 
possible to observe increasing strength and muscle 
mass, when compared to the group that performed 
training without supplementation. The amount used 
in this study could have been enough to generate 
such changes in female rats, unlike the mentioned 
study, since the growth mechanism of the skeletal 
muscle is similar both for humans and rats. 
The implication of this study may be extended 
to cases in which there is the need to maintain mus-
cle mass in specific diseases, which lead to strength 
loss27-29. Bogdanovich et al.30 tested myostatin in-
hibition in vivo in mdx mice, and results revealed 
increasing weight, mass, size and absolute muscle 
strength, with significant decrease in muscle degen-
eration. They concluded that myostatin blockade 
offers treatments for diseases associated with mus-
cle loss, for instance, Duchenne muscle dystrophy. 
The  expression of the GDF-8 gene is similar in 
muscle tissues of patients with two types of muscle 
dystrophy (Duchenne and Becker), with different 
levels of clinical compromise31.
In a recent study, a swimming protocol was applied 
(45 minutes, twice a day, for 4 weeks) to rats submit-
ted or not to a diet with high fat level.  Animals who 
swam and were not under a special diet presented 
significant reduction in the mRNA expression for 
myostatin in the analyzed gastrocnemius muscle, in 
comparison to the group that did not exercise; but the 
result was not repeated when groups who received a 
fat-rich diet were compared32. The swimming proto-
col used in this study may have been potentialized by 
the use of a supplement with Cystoseira canariensis.
These findings indicate a higher maximum load 
supported by the muscles of rats that received sup-
plementation, be it compared to groups C or Sw. 
For the S group, it is possible that the mass gain also 
contributed with the increasing resistance to the 
conducted traction test. However, the group that 
swam and received supplement had gained less body 
mass, but presented with resistance to the maximum 
load when compared to the Sw group, not differing 
from the C group.
In relation to maximum stretch limit, groups that 
received supplementation (isolated or associated with 
swimming) were the ones that presented higher values. 
When it is possible to observe that the muscles 
stretch more with the load at the maximum limit, it 
becomes more rigid, which is a reflection of the elas-
tic phase of the muscle. This occurred with the group 
that received only the supplementation. This result 
is a positive indication of the action of Cystoseira ca-
nariensis on the muscle, once higher values were also 
observed for the maximum load in these muscles, 
making them more resistant to lesion and/or rupture. 
This resistance has been observed by other authors by 
other authors, and it indicates that the traction trial 
is a form of analysis to preserve the physiological as-
pects of the muscle24,33,34.
The fact that the gastrocnemius muscle of animals 
who received Cystoseira canariensis presented better 
results for the studied mechanical properties indi-
cates a possible change in the structure of this muscle 
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among female rats, which could not be confirmed 
due to the lack of histological analysis — a limitation 
of this study. However, supplementation proved to be 
efficient during these eight weeks of treatment when 
it comes to the performance of the muscle facing the 
imposition of the traction load. 
CONCLUSION
The supplement containing myostatin inhibitor seems to 
have an anabolic effect on the muscle of the animals, inclu-
ding in the contribution for body mass gain. Also, associa-
ted or not to swimming, it promotes increasing resistance 
to the maximum load, in the traction test, in the gastroc-
nemius muscle of younger female rats, which becomes a 
positive indication for the improving muscle performance. 
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